Jevil, exactly right. Most pink sheet companies and most start up companies need capital to grow. You can place PRED in this group. However, PRED has assets and potential that go way beyond your average start up and have already developed way beyond your average start up.
Those who are short take the perspective that all start ups eventually fail. No matter what PRED accomplishes, some of the largest shorts will never believe it until it's too late.
Yes PRED needed capital last year and at the same time the demand slowed for stem cells.
NOW, everything has changed. Demand for stem cells is improving rapidly and their Covid test kits biz is about to ramp up and then explode.
Shorts are scrambling and some are on this board, pretending to be neutral but are actually looking for any little item that they can use to write another hit piece with the sole intention to create doubt and scare shareholders.
But the ramp up and growth are now inevitable and already starting. PRED's stock price will be A LOT HIGHER before these shorts have a clue. And that's how the best short squeezes happen. Depending on how this plays out, the ultimate short squeeze could take PRED from $10 to $20 or $20 to $30 or both.
It's going to be fun for those that stick with this for the next 12 months.
News 
Market Data 
Discover 
